COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease (DREPHAPLO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03240731
Recruitment Status : Recruiting
First Posted : August 7, 2017
Last Update Posted : February 6, 2019
Association Clinique Thérapeutique Infantile du val de Marne
Information provided by (Responsible Party):
Nathalie Dhédin, Saint-Louis Hospital, Paris, France

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : September 2020